#United States #Premier Inc. #Miamisburg #Aerobiotix #Illuvia Sense

Aerobiotix Recognized for Advancements in Infection Control

Aerobiotix USA, LLC, has recently received a prestigious Technology Breakthrough Designation from Premier, Inc. for its cutting-edge Room Environment Infection Prevention Products. This recognition stems from the organization's commitment to improving patient safety and clinical outcomes through innovative healthcare solutions.

Effective from March 16, 2026, Aerobiotix's Illuvia Sense continuous air disinfection system will be available to Premier members, who can access special pricing and terms negotiated by Premier. Michael Schmitz, President of Aerobiotix, expressed pride in partnering with Premier to provide healthcare providers with a scalable solution for one of the often overlooked sources of contamination: the air itself.

Illuvia Sense: A Smart Solution

The Illuvia Sense system leverages an integrated approach, combining high-efficiency particulate air (HEPA) filtration, ultraviolet germicidal irradiation (UVGI), and smart particle sensing technologies. This combination is specifically designed to not only capture airborne contaminants but also inactivate them continuously. By integrating this system with existing HVAC infrastructure, it actively monitors air quality in real-time.

Impact on Healthcare

Numerous independent peer-reviewed clinical studies have validated the effectiveness of Aerobiotix's system in reducing surgical site infections (SSIs) and airborne contamination. The Illuvia Sense has proven to be a pivotal tool in healthcare facilities, helping to diminish the risk of SSIs and enhancing the overall air quality in operating rooms and care areas. This is crucial in maintaining both patient and caregiver safety in medical settings.

Environmentally friendly and efficient, the Illuvia Sense not only advances infection control but also supports healthcare facilities in their operational goals. Premier’s role as a technology-driven healthcare improvement company amplifies this impact, as they connect providers with suppliers and payers to facilitate significant advancements in the healthcare industry.

About Aerobiotix

Founded with a mission to enhance environmental safety in healthcare, Aerobiotix continues to innovate within the sector. Their flagship product, Illuvia Sense, stands as a testament to their dedication to improving patient care and safety through technologically advanced air decontamination solutions. The integration of engineering with evidence-based practices ensures a comprehensive approach to infection prevention.

This recognition marks an important milestone for Aerobiotix as it solidifies their position as leading innovators in healthcare technology. By focusing on air quality improvements, they are making strides toward minimizing infection risks in medical environments, contributing positively to community health outcomes.

For more information on the Illuvia Sense system and Aerobiotix's initiatives, visit aerobiotix.com/illuviasense.

Conclusion

As the healthcare landscape becomes increasingly focused on safety and efficacy, Aerobiotix's advancements offer a glimpse into the future of infection prevention technology and illustrate the profound impact that air quality can have on patient health. The collaboration with Premier, Inc. not only showcases a commitment to innovation but emphasizes the importance of partnerships in the drive for healthcare improvement.